$QNTM

$3.24▲ -0.6% YTD

7 SEC 13D/G filings tracked · Last updated Oct 6, 2026

Filing History

CP $3.24▲ -0.6%Oct 6, 2026 · ThinkSabio Blog

$QNTM - Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sc…

SEC 13D/G

QNTM - Quantum BioPharma Ltd. - SEC Filing Update (05-OCT-2026) | ThinkSabio - Stocks Simplified

$3.49▼ -50.21%Oct 5, 2026 · ThinkSabio Blog

$QNTM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #QNTM Quantum BioPharma Ltd. : $3.49 Sector: Healthcare | YTD: 🔽…

News

QNTM ▲ +1.6% - Quantum BioPharma Ltd.

CP $3.70▲ +1.6%Sep 17, 2026 · ThinkSabio Blog

$QNTM - Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target…

News

QNTM ▲ +1.7% - Quantum BioPharma Ltd.

CP $3.50▲ +1.7%Sep 15, 2026 · ThinkSabio Blog

$QNTM - Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto…

News

QNTM ▲ +2.7% - Quantum BioPharma Ltd.

CP $3.38▲ +2.7%Sep 11, 2026 · ThinkSabio Blog

$QNTM - Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials…

News

QNTM ▲ +3.1% - Quantum BioPharma Ltd.

CP $3.37▲ +3.1%Sep 9, 2026 · ThinkSabio Blog

$QNTM - Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment…

SEC 13D/G

$QNTM SEC Filing Update (08-JUL-2026) | ThinkSabio - Stocks Simplified

$3.27▼ -53.35%Jul 8, 2026 · ThinkSabio Blog

$QNTM SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #QNTM : $3.27 Sector: Healthcare | YTD: 🔽 -53.35% The SEC disclo…